Best Pathway To Interchangeable Insulins Is In The Eye Of The Beholder

 
• By Sue Sutter
  
medicine, diabetes, glycemia, health care and people concept - close up of woman hands making injection with insulin pen or syringe - Image
Stakeholders have different views on how to secure interchangeability designations for biosimilar insulins. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Biosimilars & Generics